WERNER MILTON H. (President and CEO) purchased 0.1% of their position (5K shares) of INHIBIKASE THERAPEUTICS, INC. on the open market
Open‑market purchase worth $4.0K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/16/2022ACC: 0000899243-22-028794
DirectorOfficer10% Owner· President and CEO
Since Dec 2020
+5K
Net shares
Net buyer
$4.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
5K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+5K
Price / share
$0.80
Trade value
$4K
% of position
0.1%
8/16/2022
5.33M→5.34M
Total
Net shares
+5K
Net value
$4K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/16/2022 | P · Purchase | +5K | $0.80 | $4K | 0.1% | 5.33M | 5.34M |
| Total | +5K | $4K | ||||||
Derivative Transactions0
No derivative transactions reported